References
- Centers for Disease Control and Prevention. National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2007. US Department of Health and Human Services, Centers for Disease Control and Prevention, GA, USA (>2008).
- Jemal A, Siegel R, Xu J, Ward E. Cancer Statistics, 2010. CA Cancer J. Clin.60(5), 277–300 (2010).
- Leitzmann MF, Ahn J, Albanes D et al. Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening trial. Cancer Causes Control19(10), 1267–1276 (2008).
- Calton BA, Chang SC, Wright ME et al. History of diabetes mellitus and subsequent prostate cancer risk in the NIH-AARP Diet and Health Study. Cancer Causes Control18(5), 493–503 (2007).
- Bonovas S, Filioussi K, Tesantes A. Diabetes mellitus and risk of prostate cancer: a meta-analysis. Diabetologia47(6), 1071–1078 (2004).
- Kasper JS, Giovannucci E. A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol. Biomarkers Prev.15(11), 2056–2062 (2006).
- Li Q, Kuriyama S, Kakizaki M et al. History of diabetes mellitus and the risk of prostate cancer: the Ohsaki Cohort Study. Cancer Causes Control21(7), 1025–1032 (2010).
- Turner EL, Lane JA, Donovan JL et al. Association of diabetes mellitus with prostate cancer: nested case–control study (protect: prostate testing for cancer and treatment). Int. J. Cancer DOI:10.1002/ijc.25360 (2010) (Epub ahead of print).
- Rodriguez C, Patel AV, Mondul AM, Jacobs EJ, Thun MJ, Calle EE. Diabetes and risk of prostate cancer in a prospective cohort of US men. Am. J. Epidemiol.161(2), 147–152 (2005).
- Hernandez DJ, Nielsen ME, Han M, Partin AW. Contemporary evaluation of the D’amico risk classification of prostate cancer. Urology70(5), 931–935 (2007).
- Chan JM, Latini DM, Cowan J, Duchane J, Carroll PR. History of diabetes, clinical features of prostate cancer, and prostate cancer recurrence-data from CaPSURE (United States). Cancer Causes Control16(7), 789–797 (2005).
- Loeb S, Helfand BT, Kan D, Issacs WB, Catalona WJ. Does diabetes mellitus modify the association between 17q12 risk variant and prostate cancer aggressiveness? BJU Int.104(9), 1200–1203 (2009).
- Gudmundsson J, Sulem P, Steinthorsdottir V et al. Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against Type 2 diabetes. Nat. Genet.39(8), 977–983 (2007).
- Stevens VL, Ahn J, Sun J et al.HNF1B and JAZF1 genes, diabetes, and prostate cancer risk. Prostate70(6), 601–607 (2010).
- Pierce BL, Ahsan H. Genetic susceptibility to Type 2 diabetes is associated with reduced prostate cancer risk. Hum. Hered.69(3), 193–201 (2010).
- Kasper JS, Liu Y, Pollak MN, Rifai N, Giovannucci E . Hormonal profile of diabetic men and the potential link to prostate cancer. Cancer Causes Control19(7), 703–710 (2008).
- Baradaran N, Ahmadi H, Salem S et al. The protective effect of diabetes mellitus against prostate cancer: role of sex hormones. Prostate69(16), 1744–1750 (2009).
- Hubbard JS, Rohrmann S, Landis PK et al. Association of prostate cancer risk with insulin, glucose, and anthropometry in the Baltimore longitudinal study of aging. Urology63(2), 253–258 (2004).
Website
- Ries LA, Eisner MP, Kosary CL et al. (Eds). SEER Cancer Statistics Review, 1975–2001. National Cancer Institute, Bethesda, MD, USA (2004) http://seer.cancer.gov/csr/1975_2001/